Literature DB >> 9448988

Evaluation, treatment, and prophylaxis of infections complicating systemic vasculitis.

M C Sneller1.   

Abstract

Infection continues to be a major cause of morbidity and mortality in patients with systemic vasculitis. The recognition and treatment of infections in these patients is a particularly difficult task because the spectrum of potential pathogens is broad and the clinical manifestations of infection often mimic those of the underlying disease. This article provides 1) a general overview of the immunosuppressive properties of agents commonly used in the treatment of systemic vasculitis, and 2) a framework for the diagnostic evaluation and treatment of various infectious syndromes in patients with systemic vasculitis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9448988     DOI: 10.1097/00002281-199801000-00006

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  2 in total

1.  Primary cytomegalovirus infection with accompanying Pneumocystis jiroveci pneumonia in a patient with large-vessel vasculitis.

Authors:  M Vetter; M Battegay; M Trendelenburg
Journal:  Infection       Date:  2010-08       Impact factor: 3.553

2.  Systemic and Central Nervous System Vasculitides.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-09       Impact factor: 3.972

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.